Previous close | 10.20 |
Open | N/A |
Bid | 18.00 |
Ask | 21.30 |
Strike | 75.00 |
Expiry date | 2024-07-19 |
Day's range | 10.20 - 10.20 |
Contract range | N/A |
Volume | |
Open interest | 8 |
ALISO VIEJO, Calif., May 28, 2024--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the following upcoming investor conferences:
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
It's been a pretty great week for Glaukos Corporation ( NYSE:GKOS ) shareholders, with its shares surging 12% to US$108...